| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.23B | 3.41B | 3.03B | 3.12B | 3.98B | 6.79B |
| Gross Profit | 1.28B | 1.39B | 1.24B | 1.21B | 1.41B | 1.56B |
| EBITDA | 674.00M | 657.00M | -3.36B | -1.29B | 222.00M | 1.57B |
| Net Income | 316.00M | 300.00M | -2.42B | -1.11B | -375.00M | 1.04B |
Balance Sheet | ||||||
| Total Assets | 15.32B | 15.82B | 18.23B | 19.72B | 22.38B | 23.33B |
| Cash, Cash Equivalents and Short-Term Investments | 564.00M | 937.00M | 739.00M | 1.54B | 3.10B | 2.97B |
| Total Debt | 7.16B | 7.44B | 10.10B | 9.79B | 10.45B | 11.16B |
| Total Liabilities | 13.50B | 13.90B | 16.61B | 17.16B | 18.58B | 19.14B |
| Stockholders Equity | 1.82B | 1.92B | 1.61B | 2.55B | 3.80B | 4.19B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.45B | -1.92B | -1.53B | -1.41B | -1.94B |
| Operating Cash Flow | 0.00 | -517.00M | -1.40B | -1.42B | -1.24B | -1.60B |
| Investing Cash Flow | 0.00 | 3.39B | 287.00M | 466.00M | 2.07B | 4.54B |
| Financing Cash Flow | 0.00 | -2.68B | 295.00M | -719.00M | -707.00M | -792.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥132.00B | 15.30 | ― | 1.79% | 8.32% | 24.36% | |
72 Outperform | ¥13.21B | 4.54 | ― | 4.80% | 6.76% | 79.58% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥2.25B | -186.91 | ― | 3.12% | -1.51% | -50.60% | |
57 Neutral | ¥3.78B | 14.35 | ― | 2.63% | -4.11% | -39.80% | |
44 Neutral | ¥3.79B | -40.43 | ― | ― | 2.60% | 80.92% | |
41 Neutral | ¥1.27B | -2.83 | ― | ― | 1.17% | 11.88% |